At 4:20 seconds into the presentation, he says they will move away from morning dosing to night dosing in "future studies" to avoid dizziness and states of confusion...
Do you think he is alluding to a new actual P3 for AD or talking about all 2-73 studies regardless of indication?
Market Data 
Markets 
AI
